Advancing the care for patients with Thrombosis
Thrombosis refers to potentially life-threatening blood clots that form in an artery or vein. A clot in the vein (usually in the leg or pelvis) is known as a Deep Vein Thrombosis (DVT) and a clot that breaks off and travels to the lungs is known as a Pulmonary Embolism (PE). Together, DVT and PE make up Venous Thromboembolism (VTE).
Blood clots do not discriminate. They affect people of all ages, races and ethnicities, and occur in both men and women. Certain factors and situations can increase the risk of developing life-threatening blood clots such as cancer, cancer treatment, major surgery, inactivity, pregnancy or genetic disposition. If you experience one of these, do not hesitate to ask your healthcare team about your risk of blood clots and which symptoms to look out for.
Blood clots are often treated with heparins and direct oral anticoagulants (DOACs), which are anticoagulants that may help prevent blood clots from forming, or stop them from getting bigger, so the body has time to break them down.
At LEO Pharma, we are proud of our disease awareness and support programmes that help empower people to have the confidence to take control of their health. CancerClot™ offers support to people living with cancer-associated thrombosis (CAT).
MAT-50576 August 2022